A study of the Influence of mevalonic acid and its metabolites on the morphology of swiss 3T3 cells by unknown
A Study of the Influence of Mevalonic Acid and  its 
Metabolites on the Morphology of Swiss 3T3 Cells 
RODNEY  A.  SCHMIDT, JOHN  A.  GLOMSET, THOMAS  N.  WIGHT, 
ANDREAS  J.  R.  HABENICHT,  and  RUSSELL ROSS 
Howard Hughes Medical Institute Laboratory, Departments of Medicine, Biochemistry, and Pathology, 
and the Regional Primate Research Center, University of Washington,  Seattle, Washington  98195. Dr. 
Habenicht's  present address is 69-Heidelberg-1,  Bergheimerstrasse 58, ludolf-KrehI-Klinik, Federal 
Republic of Germany 
ABSTRACT  We  used two model systems to investigate the effect of compactin, a competitive 
inhibitor of fl-hydroxy fl-methylglutarylcoenzyme A reductase, on the shape of Swiss 3T3 cells. 
We maintained cells in a quiescent state in medium deficient in platelet-derived growth factor 
(PDGF), or we added PDGF to quiescent cells to initiate traverse through a single cell cycle. In 
both systems, the cells responded to compactin  by acquiring a characteristic rounded shape. 
Cell rounding seemed to depend on an induced deficiency of mevalonic acid (MVA)  since the 
response could be prevented or reversed by adding MVA to the culture medium. Compactin- 
induced rounding appeared  in PDGF-stimulated cells concomitantly with a compactin-medi- 
ated  inhibition  of  DNA  synthesis, and  both  effects  had  similar  sensitivities to  exogenous 
compactin  and  MVA.  However,  cell  rounding  seemed  to  be  unrelated  to  other,  previously 
observed  effects  of  MVA  deficiency.  Compactin  did  not  influence the  total  content of  cell 
cholesterol, and little cholesterol was formed when we added radioactive MVA to round cells 
to effect shape change reversal. Measurement of the dolichol-dependent glycosylation of cell 
protein revealed  no evidence of dolichol deficiency.  In addition,  reversal of cell rounding by 
MVA  was  not  prevented  by  concentrations  of  tunicamycin  that  effectively  blocked  the 
incorporation of  radioactive mannose into cell protein or by concentrations of cycloheximide 
that blocked  protein synthesis. Taken  together, our results suggest a new role for MVA or its 
products in the maintenance of cell shape. 
Two different inhibitors of mevalonic acid (MVA) synthesis, 
25-hydroxycholesterol and compactin (ML 236B),  have been 
noted to block replication and induce cell rounding in several 
cell culture systems. Kandutsch  and Chen  (1) originally ob- 
served these combined effects 24-48 h after treating mouse L- 
cells with 25-hydroxycholesterol. Kaneko et al. (2) later ob- 
tained similar results by adding compactin to L-cells or human 
skin  fibroblasts. Cornell  and  Horwitz  (3)  recently reported 
similar findings after adding 25-hydroxycholesterol or compac- 
tin  to  L6  myoblasts.  These  results  raise  the  possibility that 
MVA may be required not only for cell replication, but also 
for  maintenance  of cell  shape.  However,  it  remains  to  be 
demonstrated that the observed changes in cell shape depend 
directly on  MVA  deficiency rather  than  on  some  indirect 
mechanism related to cell proliferation. 
Cell-culture systems that allow control of cell proliferation 
may be used to investigate the role of MVA in maintenance of 
cell shape. We have been using two such systems in studies of 
the effects of platelet-derived growth factor (PDGF) on Swiss 
3T3 cells (4, 5). In one, cells are maintained in a quiescent but 
metabolically active state in plasma-derived serum (PDS); in 
the other, cells are changing both morphologically and meta- 
bolically as they traverse through a single cell cycle in response 
to  added  PDGF.  We  havc  already shown  that  addition of 
compactin to PDGF-stimulated cells leads to reduced incor- 
poration of [aH]thymidine into DNA within one cell cycle, and 
that this effect is caused by MVA deficiency (4). In the present 
study, we used the same systems to address three main ques- 
tions related to the effects of compactin on ceil shape: does 
compactin  affect  cell shape  through  an  inhibition of MVA 
synthesis?  Is  compactin-induced  rounding  a  specific conse- 
quence of MVA deficiency or does it follow a general pertur- 
THE  JOURNAL OF  CELL BIOLOGY  • VOLUME  95  OCTOBER  1982  144-153 
144  ©  The Rockefeller  University Press  - 002t-9525/82/10/0143/10  $1.00 bation of cell metabolism? Does the effect of compactin on cell 
shape depend on a  deficiency of a  known product of MVA 
metabolism such as cholesterol or dolichol? 
MATERIALS  AND  METHODS 
Materials 
DL-mevalonic acid lactone, dolichot, dolichol monophosphate, ubiquinone, 
and cycloheximide were obtained from Sigma Chemical Co.,  St.  Louis, MO, 
Cholesterol and cholesteryl oleate were from Applied Science Die., Milton Roy 
Co.,  Laboratory Group, State College, PA. Tunicamycin (lot #361-91J-165-A) 
was the gift of Dr. R. Hamill (Eli Lilly and Co.,  IndianapoLis,  IN). (MethylJ~H)- 
thymidine (6.7 Ci/mmole), (RS)-(5-SH)-mevalonolactone (2 Ci/mmol), L-lt4C- 
(U)]leucine  (355  mCi/mmol),  2-[14C]acetic  acid  (55  mCi/mmol),  and  D-(2- 
:SH(N))-mannose  (14.5 Ci/mmol) were purchased from New England Nuclear, 
Boston,  MA. Compactin (ML-236B) was the generous gift of Dr. A. Endo and 
was converted to its sodium salt before use as previously  described (4). Dulbecco's 
modified Eagle tissue culture medium (4.5 g glucose/L), medium supplements, 
and trypsin were obtained from Gibco Laboratories, Grand  Island Biological 
Co.,  Grand Island, NY. 
Phosphate-buffered saline (PBS) without Ca  ~÷ or Mg  2+ was prepared accord- 
ing to Dulbecco (6).  Low density lipoproteins (LDL;  1.019 <  d <  1.063) were 
isolated from two  healthy, fasting adult women as previously described (7). 
Cholesterol:phnspholipid  liposomes (measured molar ratio = 0.89) were prepared 
from purified cholesterol and a mixture of soybean phnsphollpids purified from 
Intralipid (AB Vitrum, Stockholm, Sweden) (C. Chen et al., in preparation.) The 
lipids were mixed in CHCIa and dried under argon. The llposomes were generated 
in 0,14  M  NaC1,  I  mM EDTA by sonication with a titanium probe (Branson 
Sonic Power Co., Danbury, CT) for 1 h (temperature maintained between 40°C 
and 50°C). Metal fragments were removed by centrifugation and the liposome 
suspension was added directly to cultured cells. 
Human  plasma-derived serum  (PDS)  deficient in  platelet-derived growth 
factor (PDGF) was prepared from normal fasting plasma as previously described 
(8). Tissue culture medium containing 5% PDS contained 2.4-2.7  mg/ml protein 
and  44-68  ~tg/ml total cholesterol. Partially purified PDGF  (CMS  III) was 
prepared as described (8) and added to ceils as a solution in I mM acetic acid. In 
all experiments an amount of CMS Ill was used that contained 5-6 times the 
mitogenic activity of 5% calf serum when assayed as described (9). 
Cell Culture 
Stock cultures of Swiss 3T3  cells were maintained essentially as previously 
described (8), supplemented with nonessential amino acids and sodium pyruvate. 
Following trypsinization, the cells were replated in medium containing 5% PDS 
at approximately 125,000 cells/35-mm tissue culture dish (Falcon Labware, Div. 
Becton, Dickinson & Co., Oxnard, CA). The medium was changed on days 2 
and 4; the cells became quiescent within 5 d and experiments were begun on day 
5 or 6 without further medium changes. Cholesterol mass was determined by gas 
chromatography as previously described (4), while protein mass was measured 
using a slight modification of the method of Lowry et aL (10). 
Scanning Electron Microscopy 
Cells in 35-mm tissue culture dishes were fixed in situ  in 3% glutaraldehyde 
(Eastman Laboratory and Specialty Chemicals, Rochester, NY) in either PBS or 
0.15  M cacodylate at room temperature for  1 h. Following a thorough rinsing 
with the same buffer, the cultures were postfixed in 1% osmium tetroxide (Ted 
Pella, Tustin, CA) buffered with 0.1 M phosphate (Sorensen's) or 0.1  M caco- 
dylate for 30 min and rinsed with distilled water. The plastic dishes were split 
into quadrants while still wet (done under distilled water) and stained en bloc 
with 2% aqueous uranyl acetate (Ted PeUa) for 30 rain. The ceils were thoroughly 
rinsed with distilled water, then dehydrated through graded ethanol (35, 50, 70, 
80, 85, 90, 95, and 100% [x 2]). The samples were critical-point dried (Tousimis 
Research Co., Rockville, MD), coated with gold-palladium, and examined in a 
JEOL 35C scanning electron microscope (Medford, MA). 
Quantification of Cell Rounding 
The culture medium was removed from each dish and the cells were fixed 
directly with 3% glutaraldehyde in PBS.  Alternatively, cells were washed once 
with PBS  and  fixed with ice-cold 5% trichloroacetic acid (TCA).  This latter 
method of fixation preserved cell shape well enough to allow scoring for round- 
ness and gave estimates of the frequency of round cells comparable to those 
obtained using glutaraldehyde fixation. Fixation by either technique did not 
affect the frequency of round cells when compared to that of unfixed control 
ceils. Three randomly selected fieMs from each of duplicate dishes were photo- 
graphed (125-fold  magnification) on a  Leitz Diaven microscope using phase- 
contrast optics. The negatives were projected onto an 8 inch x  10 inch grid using 
a  Leitz Prado universal projector and all ceils were scored (see below) whose 
nuclei were projected within the grid. The frequency of round ceils in each dish 
was determined using all photographs from that dish. The mean and standard 
deviation for each experimental group reflect interdish variations in the observed 
frequency of round cells. Ceils were scored as "round" if  they had formed phase- 
bright spheres that were held to the culture dish by cytoplasmic processes. Ceils 
that did not satisfy these criteria were scored as "nonrounded'" even when their 
shape was consistent with incomplete cell rounding. Cells were scored as round 
or nonrounded without consideration of the size, length and number of processes, 
or the appearance of the cell surface. 
A utoradiograph y 
After 3T3  ceils were labeled with [SH]thymidine,  the labeling medium was 
removed and the cells were fixed for  20  rain with Holley's fixative (11)  and 
extracted six times with 70% ethanol over a period of 3 d. After they had dried, 
dishes were coated with 60% (v/v) Kodak NT-B2 emulsion, dried, and exposed 
2 wk at 4°C before being developed. The more concentrated emulsion solution 
is necessary to coat the  round  ceils (Personal communication, S.  Hauschka, 
University of Washington). The dishes were stained lightly with hematoxylin (2 
min), washed with water, dehydrated in ethanol and dried. 500 ceils/dish were 
simultaneously scored for roundness (as described above) and incorporation of 
[SH]thymidine  on a Zeiss microscope at 400-fold magnification. It was essential 
to adjust the microscope so that round, labeled cells could be distinguished  from 
round, unlabeled cells. For this purpose, we used a dish of ceils that had been 
treated with cytochalasin E and [SH]thymidine  to induce rounding in ceils that 
were incorporating [aH]thymidine. 
Incorporation of [aH]Thymidine,  [~C]Leucine, 
and [3H]Mannose into TCA-insoluble Material 
After incubation of cells with 2 #Ci/ml l:~H]thymidine or 0.7 #Ci/ml [t4C]- 
leucine, the medium was removed and the monolayer washed once with PBS at 
room temperature. Then 2 ml fresh,  ice-cold 5% TCA were added and the cells 
kept at 0--4°C for at least 20 rain. Cultures were photographed for quantification 
of cell rounding and then reextracted for at least 20 min with additional 5% TCA. 
After the TCA was removed, the cell monolayer was dissolved in 1.5 ml 0A N 
NaOH and transferred to a liquid scintillation vial. Then 0.5 ml glacial acetic 
acid and 10 ml Aquasol (New England Nuclear, Boston, MA) were added and 
aH in the samples was counted in a Packard Tri-Carb liquid scintillation  counter. 
Incorporation of radioactivity into TCA-insoluble material by ceils incubated 
with 45 #Ci/ml [SH]maanose  was determined by the same procedure. Efficacy of 
the TCA extraction technique was demonstrated by the fact that only 2.5% of the 
radioactivity remaining after two TCA extractions could be released by further 
TCA extractions. When PDGF-stimulated cells were labeled with [SH]mannose 
for 4 h  and fractionated by the procedure of Adamany and Spiro (12) at least 
97.5% of the TCA-insoluble material had the solubility properties of protein, 
0.8% of dolichyl phosphomannose,  0.8% of dolichyl saccharide, and 0.6%  of 
mannose and mannose nucleotides. 
Incorporation of Exogenous AlVA into Cellular 
Compounds Comigrating with M VA, 
Cholesterol, and Cholesteryl Ester 
PDGF and 30 tiM compactin were added to quiescent 3T3 cells in i00-mm 
dishes. The cells were photographed 26 h later (to quantify cell rounding) and 
500 gM tritiated MVA (98 mCi/mmob was added. After 110 min the cells were 
rephntographed and washed once with 20 ml PBS and twice in 10 ml PBS before 
being scraped into 10 ml PBS using a Teflon policeman. The cells were pelleted 
at 800 g and total MVA uptake was determined by dissolving  some of the pellets 
in 0.5% SDS and counting in 10 ml Aquasol. Cholesterol, cholesteryl oleate, free 
dollchol, ubiquinone, and MVA standards in acetone were added to the pellets, 
which were then extracted exhaustively with cold acetone. The pooled acetone 
extracts were dried under N2, dissolved in a small volume of acetone, and spotted 
on 250-/* Silica Gel H thin-layer chromatography plates (Analabs, Inc., Foxboro 
Co.,  North Haven, CT) that had been pre-activated for 30 min at 110°C.  The 
plates were developed in heptane:anhydrous diethyl ether:methanol (90:7Y2:15), 
which separates cholesterol (Rf:.20),  and cholesteryl oleate (Rf:.60) from MVA 
(Rf:0),  dolichol monophosphate (Rf:0),  free dolichol (Re:.33), and ubiquinone 
(R~:.47) (Fig. 1). The lipids were visualized with iodine vapor, separately scraped 
into 10 ml Aquasol, and counted. The acetone-insoluble material was dissolved 
in  0.5%  SDS  and  counted.  Recovery  of 3H  label from  the  cells using this 
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chromatography, lipid standards in acetone or chloroform:methanol 
(2:1)  were  spotted  on  a  silica-gel  H  plate,  separated in  heptane: 
anhydrous diethyl ether:methanol (90:71/2:15) and visualized as de- 
scribed.  Resolution of the lipid standards was not affected by mixing 
the standards  either with each other or with  lipid extracts  from 3T3 
cells. (A) Dolichol monophosphate,  20 #g and squalene, 43 #g. (B) 
Cholesteryl oleate, 500#g. (C) Ubiquinone, 100/.tg. (D) Dolichol, 20 
#g. (E)  Cholesterol,  500 p.g. (F)  Mevalonolactone, 200 #g. 
procedure was 102%. Cholesterol recovery, as measured by preincubating ceils 
for 21.5 h with [14C]cholesterol and determining total incorporation and recover- 
able cholesterol as described above, was at least 95%. 
Incorporation  of [~4ClAcetate into Cholesterol 
Quiescent 3T3  ceils were treated with PDGF and various concentrations of 
compact.in, After 22 h, they were pulsed with [~4C]acetate (14.5 pCi/ml; 55 mCi/ 
retool) for 3 h and the incorporation of 14C into digitonin-predpitable  sterols was 
measured as previously described (4), 
RESULTS 
Effects of Compactin and Mevalonic Acid on 
the Shape of Quiescent Swiss 31-3 Cells 
We used quiescent Swiss-3T3 ceils to determine whether the 
effects of compactin on cell shape depend on the induction of 
MVA  deficiency  and  whether  these  same  effects  show  an 
obligatory requirement for cell proliferation. We obtained the 
quiescent cells by maintaining sparsely plated 3T3 ceils in 5% 
PDS for 5 d. When viewed by SEM (Fig. 2A), these control 
ceils were extremely flat and widely spread over the substratum, 
and formed a confluent monolayer at a low cell density. 
When we treated these quiescent cells with 30 gM compactin, 
individual cells assumed  a  round  shape  (Fig. 2 B)  while re- 
maining attached  to  the  dish by 2--4 cytoplasmic processes. 
Round cells were present in significant numbers within 20 h of 
exposure to compactin and their number increased with time 
(Fig. 3) in each of five experiments. This shape change was 
completely prevented when 50 #M MVA was added to the cells 
along with compactin. Compactin-induced cell rounding could 
also be rapidly reversed by the addition of MVA. When  10 
mM MVA was added to quiescent, rounded cells, changes were 
noticed within  10 min and most cells lost their round shape 
within 40 min (Fig. 2 C). Cell spreading continued during the 
next 6 h until the treated cultures were indistinguishable from 
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control cultures (Fig. 2 D). These findings provide strong evi- 
dence that compactin's effect on the shape of quiescent Swiss- 
3T3 cells depends on the induction of MVA deficiency. 
To  rule  out  the  possibility that  compactin-induced  cell 
rounding in  these quiescent cultures might be confined to  a 
small subpopulation of proliferating cells, we labeled cultures 
in one experiment with [3H]thymidine for 31 h in the presence 
or absence of compactin and processed the ceils for autora- 
diography. >50% of the compactin-treated cells became round 
within this period, whereas only 1% of either compactin-treated 
or control cells incorporated [3H]thymidine. Thus, development 
of compactin-induced cell rounding clearly does not require 
cell proliferation. 
Effects of Compactin and Mevalonic Acid on 
the Shape of PDGF-stimulated Swiss 3T3 Cells 
We  used  PDOF-stimulated  Swiss  3T3  cells  to  study  the 
effects of compactin and MVA on the shape of cells that were 
progressing through a single cell cycle. When we added PDGF 
to  quiescent  control cells in  the  absence  of compactin,  the 
mitogen itself  consistently induced dramatic effects that seemed 
analogous to effects observed previously (13-17) in other pro- 
liferating cells. Ruffles and microvilli appeared over the nu- 
cleus within 20 min (Fig. 4A), and by 45 min some cells had 
retracted from the substratum and acquired a spherical shape, 
while  remaining  attached  to  the  dish  by  5-10  cytoplasmic 
processes  (Fig.  4B).  The  entire  cell  surface,  including  the 
surface of these processes, was covered by numerous microvilli. 
This mitogen-induced cell rounding was transient, and peaked 
within 90-150 rain (Fig. 5A) in two experiments in which the 
kinetics of this rounding were quantified. The maximum per- 
centage of round cells seen at one time varied between 26 and 
46%.  After  rounding  up,  the  cells  flattened  out  again  and 
became slightly more angular and elongated than the original 
quiescent  cells. They  then  became  progressively more elon- 
gated with time (Fig. 4 C) until they entered mitosis, about 30 
h after addition of PDGF. 
Addition of PDGF and 30 gM compactin to quiescent ceils 
produced two drug-dependent alterations of the morphologic 
responses to mitogenic stimulation. First, in four experiments 
compactin affected the early rounding response to PDGF by 
causing a small but significant increase in the number of round 
cells seen during the first 5 h (Fig. 5A). No effects ofcompactin 
on the shape or surface features of individual round cells were 
identified. As in control cultures, the early rounding was tran- 
sient  and  the  cells  soon  reacquired  a  fiat  shape.  The  time 
needed for all cells to reacquire a flat shape varied between 4 
and 7 h in different experiments. The second effect of compac- 
tin was to induce cells to round up at the time expected for 
DNA synthesis. The appearance of the round cells at this time 
(Fig. 4D) differed from that seen earlier in response to PDGF 
(Fig.  4B)  in  that  the  cell surface  was  smoother  and  fewer 
cytoplasmic processes attached the cells to the dish.  In fact, 
their appearance resembled that of quiescent cells that  had 
rounded up in response to compactin (Fig. 2 B). 
We observed a  similar late ceil-rounding when  we  added 
compactin at different times after the initiation of cell cycle 
traverse (Fig. 5 B). Round cells appeared after a  temporal lag 
whether we had added the drug concomitantly with PDGF or 
10 or 20 h afterward. Although the length of the lag seemed to 
decrease as the cells progressed through the cell cycle, the rate 
of accumulation of rounded cells was approximately the same. FIGUR[  2  Scanning electron micrographs showing the response of quiescent Swiss 3T3 cells to compactin  and MVA. Cells were 
maintained at low cell density in 5% PDS for 5 d  before 30 P.M compactin was added. 381/2 h  later, 10 mM MVA was added to the 
appropriate dishes. At the times indicated, the cells were fixed and processed for SEM as described in Materials and Methods. (A) 
Quiescent control cells.  The cytoplasm is thinly spread over a large area and the surface is relatively smooth, x  550. (B) Quiescent 
cells treated with  30 p,M compactin  for 35 h.  x  1900. The spherical cells are held to the dish  by 2-3 cytoplasmic  processes;  few 
microvilli or blebs are found on the cell surface. (C) Quiescent cells treated with 30 P.M compactin for 381/2 h followed by 10 mM 
MVA for 45 rain. X 1200. Cells have lost their round shape and have begun to spread over the substratum; the cell surface remains 
smooth.  (D)  Quiescent cells treated with  30 P.M compactin  for 381/2 h  followed by 10 mM  MVA for 61/4 h,  x  650. Cells are now 
indistinguishable from quiescent controls. Bar, 10 p,m. 
FIGURr  3  Kinetics  of  00 
compactin-induced  cell  so 
rounding  in quiescent  cul-  ~ 40 
tures.  30  P.M  compactin 
was added to cells that had  ~ 30 
been  maintained  in  5%  ~ 2o 
PDS  for  5  d.  At  the  times  ~0 
shown,  duplicate  dishes 
were  fixed  and  photo- 
graphed  for quantification 
20  25  3'0  35 
Time (h} 
of cell rounding as described in Materials and Methods. Data shown 
represent mean --- 1 s.d.  (O)  no addition; (I)  30 p,M compactin. 
Thus, compactin affects the early rounding of Swiss 3T3 ceils 
that occurs in response to PDGF, and also induces a  second 
rounding that it is not necessarily limited to a fixed time-point. 
The late effect of compactin on the shape of PDGF-stimu- 
lated cells could always be prevented by addition of 100/tM 
MVA to the culture medium. Moreover, the late, compactin- 
induced cell rounding could always be rapidly reversed by the 
addition of MVA to the culture medium (Fig. 6).  Upon addi- 
tion of 10 mM MVA, cell spreading began within 5 min, most 
ceils reacquired a  fiat shape within 20 min (Fig. 4E), and the 
ceils  became  indistinguishable from  the  elongated,  PDGF- 
stimulated control cells within 150 min (Fig. 4 F). 
The rate of the shape change reversal process depended on 
the concentration of MVA added. As little as  100 #M  MVA 
caused a significant number of cells to lose their round shape 
within 5 h, but higher concentrations were required to effect 
more  rapid  shape  change  reversal.  Two  lines  of  evidence 
suggest that this dependence on concentration was related to 
the relative impermeability of the ceils to added MVA. First, 
the rate of net uptake and metabolism of exogenous MVA was 
comparable to the rate of fluid pinocytosis (as measured by the 
rate of [14C]sucrose uptake) and was not saturated between 5 
and 275 ttM added MVA (not shown). Second, little MVA was 
taken up and metabolized by cells during shape change rever- 
sal. Thus, when we added 500/~M 3H-labeled MVA to round 
cells 25.5 h after adding PDGF and 30/~M compactin, reversal 
of cell rounding occurred during a  2 h interval (35% rounded 
SCHMIDr Er  AL.  Mevalonic Acid Affects 37-3 Cell Morphology  147 FIGURE 4  Scanning  electron micrographs showing the responses of quiescent cells to PDGF, compactin, and MVA.  PDGI:  +  30 
~M compactin was added at 0 h to cells that had been maintained in 5% PDS for 5 d. 10 mM MVA was added to appropriate dishes 
26 h later. At the times indicated, cells were fixed and processed  for SEM as described in Materials and Methods. (A) Cells fixed 22 
rain after addition of PDGF alone. ×  1800. Marked surface ruffling and microvillus formation are seen above the cell nucleus. (B) 
Cells fixed 2 h after addition of PDGF alone, x  1050. The spherical cell is held to the dish by multiple cytoplasmic processes and 
the cell surface displays extensive microvillus formation. (C) Cells fixed 24 h after addition of PDGF alone, x  1500. The cells have 
assumed a thickened, highly elongated shape whereas the surface is again relatively smooth. (D) Cells fixed 24 h after addition of 
PDGI  ~ and 30/zM compactin, showing spherical cells  held to the dish  by 2-4 cytoplasmic processes, x  2000. The cell surface is 
generally smooth, although a few small  blebs are present. (E)  Cells treated with  PDGF and 30 #M compactin for 26 h and then 
treated for 20 rain with 10 mM MVA. x  1400. Most cells have assumed a thickened, elongated shape with a smooth cell surface. 
(F) Ceils treated with  PDGF and 30/~M compactin for 26 h and then treated for 150 min  with  10 mM MVA.  x  1300. Cells have 
reassumed an elongated shape indistinguishable from that of control cells (C). Bar, 10/~m. 
ceils --~  4%  rounded cells)  while  radioactivity recovered  as  stimulated  3T3  cells  contained  cholesterol  equivalent 
MVA or other products was equivalent to approximately 150 
x  106 molecules of MVA per cell. For comparison, PDGF- 
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to 
~520,000 ×  106 molecules of MVA per cell at this time (cal- 
culated from Table I). 4O 
~20- 
lO- 
0 
I 
~0  ~0  ~0  ~o  ~0  ~0  2~0  2~o  2~0 
Time  (min) 
B 
75- 
£E 
25- 
0  ,  --  -  1  ,  =  5  ~0  15  20  25  30 
Time (h) 
FIGURE  5  Kinetics  of  cell  rounding  in  PDGF-stimulated  cultures. 
(A)  Enhancement of PDGF-induced cell  rounding by 30 p,M com- 
pactin. PDGF ±  30 p,M compactin was added at 0 min to quiescent 
cells.  At  times  shown,  dishes  were  fixed  and  the  percentage of 
round cells quantified as described in Materials and Methods.  (Q) 
PDGF  only;  (,i,)  PDGF  plus 30 #M  compactin.  (B)  Kinetics of  the 
late,  compactin-induced  cell  rounding  in  PDGF-stimulated  cells. 
PDGF  was added at 0  h  to quiescent 3T3 cells.  30 #M  compactin 
was added either with  PDGF  (&),  10 h  later (A), or 20 h  later (O). 
Control  dishes  received  PDGF  alone  (O).  At  the  times  shown, 
duplicate dishes were fixed and the percentage of round cells was 
quantified  as described  in  Materials and  Methods.  The early cell 
rounding was not necessarily maximal at the 3*/4 h time-point. Data 
represent the mean ±  1 SD of duplicate dishes. 
Relation between Compactin's Effects on Cell 
Shape and DNA Synthesis 
Having found that  compactin  causes  rounding of PDGF- 
stimulated ceils at about the time expected for DNA synthesis, 
we investigated the relation between this effect and the com- 
pactin-induced block in DNA synthesis that we had previously 
demonstrated in the same cell system (4). We examined the 
sensitivity of the  two  effects  to  compactin  and  MVA,  the 
temporal correlation between the two effects, and the frequency 
of occurrence of the two effects in individual cells. When we 
treated PDGF-stimulated cells in three experiments with vary- 
ing concentrations of compactin (Fig. 7A), we found that the 
two effects showed a  similar sensitivity to the drug. Further- 
more, similar concentrations of MVA were required to prevent 
the induction of each effect by 15 #M compactin (Fig. 7 B) in 
the same experiments. When we compared, in two experiments, 
the time of appearance of the two effects in cells that had been 
simultaneously treated with PDGF and compactin, the effects 
became apparent concomitantly (Fig. 8),  and the round cells 
were  more  numerous  than  cells  that  were  prevented  from 
incorporating labeled thymidine into DNA. These observations 
suggested that  the  two  effects might  be  linked.  Three  other 
observations suggested, however, that this linkage may not be 
tight or invariable. First, autoradiographic assessment of the 
incorporation  of [3H]thymidine  into  individual cells  always 
revealed some round cells that had not been prevented from 
incorporating the label (not shown).  Second, the correlation 
between compactin-induced rounding and blocked incorpora- 
tion of labeled thymidine in individual cells varied significantly 
both  between  three  experiments and  as  a  function  of time 
within two experiments. Finally, the two effects showed some- 
what different kinetics when compactin was added 15 h  after 
PDGF  in  a  single  experiment:  within  the  first  few  h  after 
addition of the drug, more cells showed blocked incorporation 
of labeled thymidine into DNA than showed cell rounding. In 
summary, both effects seem to be similarly sensitive to MVA 
availability, but the tightness of their linkage within individual 
ceils remains to be established. 
Relation of Compactin-induced Cell Rounding 
to Cholesterol,  Dolichol, and Protein Synthesis 
Inhibition  of MVA  synthesis  in  dividing  cells  has  been 
reported to affect cellular cholesterol mass (1, 3) and dolichol- 
dependent glycosylation (18). To investigate the possibility  that 
compactin-induced changes in cell cholesterol content might 
account  for  the  influence  of the  drug  on  cell shape  in  our 
experiments, we studied sterol biosynthesis in relation to com- 
pactin-induced cell rounding, measured the content of choles- 
terol in PDGF-stimulated cells as a function of the addition of 
compactin or MVA, and tested the ability of added cholesterol 
to prevent or reverse a compactin-induced shape change. When 
we  added varying concentrations of compactin at  0  time  to 
PDGF-stimulated cells, then pulsed the cells with [~4C]acetate 
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FIGURE  6  Kinetics of reversal  of compactin-induced cell rounding 
by MVA  in  PDGF-stimulated cultures.  PDGF  +  30 fl,  M  compactin 
was added to quiescent cells.  After 26 h, 10 mM MVA was added to 
the  appropriate dishes  (0  min).  Cultures  were  fixed  at  the  times 
shown and the percentage of rounded cells quantified as described 
in  Materials  and  Methods.  (O)  PDGF  only;  (A)  PDGF  +  30 p.M 
compactin;  (A)  PDGF  +  30 #M  compactin  +  10  mM  MVA.  Data 
points represent the mean ±  1 SD of duplicate dishes. 
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FIGURE  7  Dependence of cell  shape and  [3H]thymidine incorpo- 
ration on compactin  and  MVA.  (A)  PDGF  and various concentra- 
tions of compactin were added to quiescent 3T3 cells to begin the 
experiment. Dishes were pulsed with 2 ktCi/ml [3H]thymidine for 30 
min  23  h  later,  then  fixed  and  analyzed  by  autoradiography as 
described  in  Material and  Methods.  (B)  In  the same experiment, 
PDGF,  15/LM compactin, and various concentrations of MVA were 
added  to  quiescent  3T3  cells.  Cells  were  pulsed  with  2  /~Ci/ml 
[3H]thymidine  for 30  min  23  h  later and  all  cells were fixed  and 
analyzed  by  autoradiography  as  described.  In  both  figures  the 
number of cells incorporating [3H]thymidine (&)  is expressed as a 
percentage of  the "PDGF  only"  control  whereas cell  rounding  is 
expressed as the percentage of nonrounded cells (A). Data represent 
mean +_1 SD of duplicate dishes. 
for 2,75 h, 22.25 h later we found that 1 #M compactin inhibited 
the incorporation of the label into digitonin-precipitable  sterol 
by 91% without causing cell rounding (not shown). Only when 
higher concentrations of compactin (15-30 #M) were used, and 
inhibition  of the  incorporation of labeled  acetate  into  cell 
sterols approached 99% was extensive ceil rounding seen, When 
we added 50 #M radioactive MVA to compactin-treated cells 
to  prevent  cell rounding,  <1%  of the  estimated  370  x  106 
molecules labeled MVA that were retained by the ceils was 
converted into unesterified or esterified cholesterol, whereas at 
least 85% of the labeled MVA was converted into other prod- 
ucts. Moreover, when we added 500 #M radioactive MVA to 
effect reversal of the  shape  change,  the  mass of cholesterol 
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synthesized during reversal (calculated from the specific activ- 
ity of the radioactive MVA added and the retained activity that 
comigrated with cholesterol) corresponded only to ~0.01% of 
the  total cell cholesterol mass.  These  results  make  it  seem 
unlikely that  the  effects of compactin  on  cell shape  in  our 
system depend on the inhibitory effects of the drug on choles- 
terol biosynthesis. Our measurements of cholesterol mass in 
PDGF-stimulated ceils support this conclusion. Cells, main- 
tained in culture in  the presence of plasma lipoproteins, in- 
creased their cholesterol mass by at least 50% within 24 h  in 
response to the addition of PDGF (Table I), an increase that 
was not altered by 15 #M compactin +_MVA. Finally, we were 
unable to prevent or reverse cell rounding by adding cholesterol 
to the culture medium as an ethanolic suspension (15/tg/ml), 
as LDL (216 #g total cholesterol/ml), or as liposomes com- 
prised of 1:1 unesterified cholesterol:phospholipid (15 #g cho- 
lesterol/ml). 
To investigate the potential relation of dolichol-dependent 
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FIGURE  8  Autoradiographic  analysis  of  the  temporal  correlation 
between the effects of compactin on cell shape and onset of DNA 
synthesis in  individual cells.  PDGF  and 0.5 p,  Ci/ml  [3H]thymidine 
+30/~M compactin were added to quiescent 3T3 cells at 0 h. At the 
times  shown,  dishes  were  processed  for  autoradiography as  de- 
scribed  in  Materials and  Methods.  Following development of the 
autoradiograms,  individual  cells  were  simultaneously  scored  for 
roundness and incorporation of  [3H]thymidine.  (A)  Accumulation 
of round cells with time in cultures treated with PDGF alone (0) or 
PDGF  +  30/~M compactin  (&).  (B)  Onset of  [3H]thymidine incor- 
poration in cells  treated with  PDGF  alone  (O)  or PDGF  +  30/~M 
compactin  (A).  Data  points  represent  mean  +1  SD  of  duplicate 
dishes. TABLE  I 
Influences of PDGF, Compactin, and MVA on Swiss 3T3 Cell 
Cholesterol and  Protein Mass 
Cholesterol 
Additions  mass  Protein mass 
pg/cell  ,ag/105 cells 
Quiescent control  34,9 +  2.4  57.3 :l: 1.3 
PDGF  54.9 ±  2.5  125.6 ±  1,2 
PDGF, compactin  53.2  +  1.1  1t7.0 ___ 7.5 
PDGF, compactin,  MVA  51.6  ±  4.3  126.6 ±  5.1 
Cell number, cholesterol mass, and protein mass were determined on separate 
dishes  of 3T3 cells thai  had  been  extensively washed with  PBS. Quiescent 
control dishes  were harvested  before addition of PDGF, whereas all others 
were harvested  24 h  after addition of PDGF +-. 15 /~M compactin  -  100 ,aM 
MVA. Values shown are mean +_t SD from triplicate dishes. 
TABLE II 
Effects of PDGF, Compactin, MVA, and Tunicamycin  on Cell 
Shape and Incorporation of [3H]Mannose into l'CA-insoluble 
Material 
Additions 
Radioactivity 
% Rounded cells  in TCA- 
insoluble 
20r/2 h  22% h  material 
net cpm~. 
Quiescent control  7.7 ±  1.6  12.1 +  6.3  183 ±  28 
PDGF  1.0 ±  1.1  0.7 ±  0,6  3430 +  213 
PDGF, compactin  32.6 ±  5.3  32.4 ±  5.9  3127 +_ 322 
PDGF,  compactin,  100  1.5 ±  0.9  3.6 ±  3.2  3349 ±  536 
~.M MVA (0)* 
PDGF,  compactin,  5(30  32.6 ±  5.3  1.1 ±  1.0  3253 ±  190 
M.M MVA (20r/2) * 
PDGF,  compactin,  tuni-  24,3 ±  8.2  22.2 ±  7.9  1321 ±  165 
camycin 
PDGF,  compactin,  tuni-  24.3  +  8.2  0.2 ±  0.4  1320 ±  89 
camycin, 500 ,tiM  MVA 
(20'/2)* 
PDGF +_ 30 p.M compactin was added  to quiescent 3T3 cells to  begin  the 
experiment. S `ag/ml  tunicamycin  was added  to appropriate dishes  192/3 h 
later.  In  some dishes,  100 `aM MVA  was added  along with  compactin  to 
prevent cell rounding, whereas in other dishes 500 `aM MVA was added 201/2 
h after compactin to reverse celt rounding. 201/2 h after the addition of PDGF 
the appropriate dishes were washed with PBS and fixed with 5% TCA, while 
45 ,aCi/ml 13H]mannose  (14.5 Ci/mmol) was added to all remaining dishes. 
These  remaining dishes  were washed  and  fixed 130  rain  later.  All  dishes 
were photographed for quantification of cell rounding, and  the incorpora- 
tion  of  [aH]mannose  into  TCA-insoluble  material  was quantified  as de- 
scribed  in Materials and  Methods. Values shown represent  the mean  +  SD 
from triplicate dishes. 
* Numbers in brackets  denote the time of addition of MVA (in hours)  after 
addition of PDGF. 
:I: Blank of 233 cpm has been subtracted  from all values. 
glycosylation  reactions  to  compactin-induced  rounding  of 
PDGF-stimulated cells, we measured the incorporation of ra- 
dioactive mamaose into cell glycoproteins. PDGF itself caused 
at least a  19-fold stimulation of mannose incorporation into 
TCA-insoluble cell material, and concentrations of compactin 
that caused 32% of the ceils to round up in 20 h did not alter 
this response (Table II). Furthermore, there was no change in 
the incorporation of radioactive mannose into TCA-insoluble 
cell material when exogenous MVA was used to prevent or 
reverse cell rounding. Finally, concentrations of tunicamycin 
that blocked mannose incorporation into protein by 62% failed 
to  enhance  compactin-induced cell  rounding  or  block  the 
reversal of cell rounding by MVA. Similar results were ob- 
tained in three other experiments. Thus,  a  block in dolichol 
TABLE  III 
Inability of Cycloheximide to Inhibit Reversal of Compactin- 
induced Cell Rounding 
% Rounded  [r4C] Leucine 
Additions  cells  incorporation 
cpm 
PDGF  2 ±  1  n.d. 
PDGF, compactin  57 ±  7  n.d. 
PDGf, compactin,  MVA  II  ±  I  6,258  ±  511 
PDGF, compactin, cycloheximide,  6 ±  7  356 ±  38 
MVA 
PDGF  ±  13  `aM  compactin  was  added  to  quiescent  3T3  cells.  10 `ag/ml 
cycloheximide was added  after 231/2 h, and 200,aM MVA and 0.67 p,  Ci/m114C- 
leucine (final specific activity 840 ,aCi/mmol) were added 30 rain later. After 
an additional 2 h all dishes were washed with  PBS, fixed with 5% TCA, and 
photographed. The incorporation of 14C into TCA-insoluble material and cell 
rounding  were quantified  as described  in  Materials and  Methods.  Values 
shown  are  mean  ±  standard  deviation of triplicate dishes,  n.d.,  not deter- 
mined. 
synthesis leading to  deficient mannosylation of cell protein 
seems an unlikely cause of the effects of MVA deficiency on 
cell shape in our cultures. 
Another product of MVA metabolism is isopentenyl tRNA. 
The specific role of this type of tRNA is unclear, and the effects 
of deficient isopentenylation of Swiss 3T3 cell tRNA remain to 
be investigated. However, a block in the synthesis of isopen- 
tenyl tRNA could not have had a generalized effect on protein 
synthesis in our system since compactin had no effect on the 
increase in protein mass in response to PDGF (Table I) and 
little effect on the rate of protein synthesis (not shown). More- 
over, when we allowed PDGF-treated cells to round up in the 
presence of compactin, preincubated them with  10 ~g/ml cy- 
cloheximide, and  then  added MVA  to  effect  shape  change 
reversal, the cycloheximide did not prevent the reversal process 
in three experiments though it inhibited protein synthesis by 
more than 94% (Table III). 
DISCUSSION 
Most of the experiments performed in this investigation focus 
on the possibility that compactin-induced rounding of Swiss 
3T3 cells reflects a specific requirement for MVA or its products 
in the maintenance of cell shape. In considering this possibility, 
several questions arise. First, does compactin's effect on cell 
shape depend on prevention of the synthesis of MVA or on 
some nonspecific action of the drug? Our experiments clearly 
show that addition of MVA to the culture medium can both 
prevent and rapidly reverse compactin-induced cell rounding. 
Moreover, other experiments (unpublished) have revealed that 
a number of additional alipbatic acids, including butyric acid, 
do not have this effect. These findings strongly suggest that 
compactin induces rounding of Swiss 3T3 cells by specifically 
preventing the synthesis of MVA. 
A  second question that arises is whether prevention of the 
synthesis of MVA causes cell rounding through a specific effect 
or through  a  general perturbation of cell metabolism. Data 
originally  obtained by Kaneko et al. (2) speak against the latter 
possibility, because these investigators found that protein syn- 
thesis, RNA synthesis, and nonsterol lipid metabolism are not 
affected by compactin in concentrations as high as 5 #g/ml 
(12.8  #M).  Moreover,  we  have  found  (unpublished  experi- 
ments) that the incorporation of [35S]sulfate and 13H]glucosa  - 
mine into macromolecules is not affected by 15/~M compactin, 
whereas  [~C]leucine incorporation is  only  slightly affected. 
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reversal of cell rounding also argues against the possibility  that 
treatment of nondividing Swiss 3T3 cells with compactin has 
a general effect on cell function within 30 h. In contrast, 3T3 
cells in  proliferating cultures begin to detach from  the dish 
after being incubated in the presence of 15/~M compactin for 
48  h  (4).  This effect  is temporally well separated from  cell 
rounding, and may reflect or presage cell death. 
A different question relates to the identity of the active factor 
involved in ceil shape maintenance. It could be MVA itself, or 
a  known  product  of MVA  metabolism such  as  cholesterol, 
dolichol, ubiquinone, or isopentenyl tRNA (19). Two previous 
studies (1,  3)  of cells treated  with 25-hydroxycholesterol or 
compactin revealed an association between altered cell shape 
and a reduced content of cell cholesterol. However, there are 
several reasons for believing that cholesterol was not the active 
factor in our experiments. First, compactin did not alter the 
total content of cell cholesterol, presumably because we main- 
tained the cells in a medium that contained plasma lipoproteins 
and studied the effects of MVA deficiency before most of the 
cells had a chance to divide. Second, adding extra cholesterol 
to the medium neither prevented nor reversed compactin-in- 
duced  cell  rounding.  Third,  only  a  very  small  amount  of 
cholesterol was synthesized from 3H-MVA in our shape change 
reversal experiments. Fourth, low concentrations of compactin 
inhibited sterol biosynthesis by 90% without causing cell round- 
ing.  Only when higher concentrations of the drug were used, 
and  inhibition  of sterol  biosynthesis approached  99%, was 
appreciable cell rounding observed. This partial dissociation of 
compactin's effects on cholesterol biosynthesis and cell round- 
ing is of special interest because it resembles the partial disso- 
ciation of compactin's effects on cholesterol biosynthesis and 
DNA synthesis observed previously (4).  This study of DNA 
synthesis provided strong evidence that the synthesis of choles- 
terol  during  the  G1  phase  of a  single  cell  cycle  is  not  a 
prerequisite for the synthesis of DNA during S. A related point 
of interest is that considerably higher concentrations of com- 
pactin are required to inhibit the biosynthesis of ubiquinone 
and  isopentenyl tRNA  by human  skin fibroblasts than  are 
required to  inhibit the biosynthesis of cholesterol (19).  This 
latter  observation  is  compatible with  the  possibility that  a 
product of MVA metabolism other than cholesterol may be the 
active factor in our system. The evidence against a  role for 
cholesterol will, however, not be complete until at least two 
further possibilities are investigated: (a) a  very small pool of 
endogenously synthesized cholesterol might be serving as an 
intermediate in the synthesis of the active factor, and (b) the 
shape  change  might  be  associated  with  a  redistribution of 
cholesterol among intracellular membranes, driven by the ab- 
sence of some other product of MVA. There is at present no 
evidence either for or against these possibilities. 
Our results also speak against the possibility  that prevention 
of the synthesis of MVA indirectly induced cell rounding by 
limiting the synthesis of dolichol. We initially considered this 
possibility  in view of the report (18) that 25-hydroxycholesterol 
can block the synthesis of dolichol and  reduce  dolichol-de- 
pendent  transfer of mannose  to  cell glycoproteins in  aortic 
smooth muscle ceils. Moreover, tunicamycin, an inhibitor of 
dolichol-dependent glycosylation reactions, has been shown to 
alter the shape of both normal and virally transformed 3T3 
cells (20).  In our experiments we sought evidence for a func- 
tional dolichol deficiency by measuring the rate of [all]man- 
nose incorporation into TCA-insoluble material. Since altera- 
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tions of the size or specific activity of the intracellular mannose 
pools might have been affected by compactin or MVA we also 
examined the effect of tunicamycin on both cell rounding and 
[3H]mannose incorporation. Neither compactin nor exogenous 
MVA affected the incorporation of radioactive mannose into 
TCA-insoluble material, and tunicamycin itself  did not prevent 
MVA-dependent reversal of cell rounding  in concentrations 
that  blocked the incorporation of labeled marmose by 62%. 
Thus,  if a  deficiency of dolichol occurred in  our system,  it 
probably did not cause cell rounding by limiting formation of 
dolichol phosphate and thus dolichol-dependent glycosylation 
of cell proteins. We presume again that the critical difference 
between our experiments and those in other laboratories de- 
pends  on  our  use  of a  cell culture system  that  permits the 
control of cell cycle traverse. 
Our results provide little direct information about the pos- 
sible relation between ubiquinone or isopentenyl tRNA and 
compactm-induced cell rounding.  Both metabolites of MVA 
seemed to be synthesized when we added radioactive MVA to 
rounded cells to effect shape change reversal. Therefore, com- 
pactin  might  have  caused  a  deficiency of both.  However, 
neither metabolite has been previously implicated as a deter- 
minant of cell structure. 
A viable possibility that remains to be investigated is that a 
product of MVA metabolism, yet to be identified, is the active 
factor involved in compactin-induced cell rounding. In shape- 
change reversal experiments (unpublished) that employed ra- 
dioactive MVA, we found that at least 25% of the label taken 
up  by the cells was incorporated into unidentified products 
that were insoluble in acetone, chloroform:methanol (2:1), or 
chloroform:methanol:water (10:10:3), but were soluble in chlo- 
roform-phenol. This material clearly merits further investiga- 
tion. 
One  question  not  directly examined  in  this  investigation 
concerns the mechanism of action of the putative active metab- 
olite of MVA. The active factor might influence the organiza- 
tion of the cytoskeleton and/or the attachment of the cytoskel- 
eton to cell membranes. Alternatively, it might influence cell 
attachment to the substrate. The recent report of Cavenee et al. 
(21)  is of interest in  this regard because these investigators 
found that  pretreatment of ceils with  25-hydroxycholesterol 
inhibits reattachment of the cells to other ceils or to artificial 
surfaces following release by trypsinization. 
A final question concerns the role of MVA or its product(s) 
in the physiologic regulation of cell structure. The cell systems 
developed in this investigation should be useful in studies of 
this role since cell shape is clearly under endogenous control 
and the cells can sequentially express several distinct shapes in 
response  to  PDGF  even  though  culture  conditions  remain 
constant. Furthermore, we anticipate that the rapid and syn- 
chronous  reversal of compactin-induced cell rounding  after 
addition of exogenous MVA will be particularly advantageous 
to investigators interested in studying cell spreading, cytoskel- 
etal assembly, and endogenous specifiers of cell shape. 
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